Easier diabetes meds for kids? liquid glibenclamide under study
NCT ID NCT02375828
First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 35 times
Summary
This study tested a new liquid version of the drug glibenclamide in 10 children with neonatal diabetes caused by a potassium channel mutation. The goal was to see if the liquid form is easier to give and as safe and effective as the standard pills. Children took the pills for one month, then switched to the liquid for four months, while researchers tracked side effects and how well parents and kids liked the new form.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL DIABETES SECONDARY TO MUTATION IN THE POTASSIUM CHANNEL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Universitaire Necker Enfants Malades
Paris, 7501, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
glibenclamide (liquid form)
What this could lead to
If successful, this could provide a child-friendly liquid version of glibenclamide that is easier to give to infants and young children with neonatal diabetes.
What could go wrong
This is a small study with only 10 participants, so results may not apply to all children. The liquid form might not work as well as pills or could cause side effects like low blood sugar.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.